René Westhovens (R Westhovens, Rene Westhovens)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 38

Top Topics

Rheumatoid Arthritis

Top Venues

Annals of the rheumatic diseases

Rheumatology international

Expert review of clinical immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Delphine Bertrand, Johan Joly, Barbara Neerinckx, Patrick Durez, Jan Lenaerts, Rik Joos, Kristof Thevissen, Tom Zwaenepoel, Johan Vanhoof, Silvana Di Romana, Veerle Taelman, Els Van Essche, Luk Corluy, Clio Ribbens, Marc Vanden Berghe, Mieke Devinck, Sofia Ajeganova, Anne Durnez, Yves Boutsen, Joëlle Margaux, Isabelle Peene, Jan Van Offel, Michaël Doumen, Sofia Pazmino, Elias De Meyst, Myroslava Kulyk, Nelly Creten, René Westhovens, Patrick Verschueren, null null
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial. RMD open 10 (3) (2024)
Peter C Taylor, Arthur Kavanaugh, Peter Nash, Janet E Pope, Georg Pongratz, Bruno Fautrel, Rieke E Alten, Ken Hasegawa, Shangbang Rao, Dick de Vries, Pieter-Jan Stiers, Chris Watson, René Westhovens
Impact of filgotinib on pain control in the phase 3 FINCH studies. RMD open 10 (1) (2024)
Peter C Taylor, Arthur Kavanaugh, Peter Nash, Janet E Pope, Georg Pongratz, Bruno Fautrel, Rieke E Alten, Ken Hasegawa, Shangbang Rao, Dick de Vries, Pieter-Jan Stiers, Chris Watson, René Westhovens
Impact of filgotinib on pain control in the phase 3 FINCH studies. RMD open 10 (1) (2024)
Peter C Taylor, Arthur Kavanaugh, Peter Nash, Janet E Pope, Georg Pongratz, Bruno Fautrel, Rieke E Alten, Ken Hasegawa, Shangbang Rao, Dick de Vries, Pieter-Jan Stiers, Chris Watson, René Westhovens
Impact of filgotinib on pain control in the phase 3 FINCH studies. RMD open 10 (1) (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases 83 (9) (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases 83 (9) (2024)
René Westhovens, Patrick Verschueren
Lessons from negative phase 3 trials in rheumatoid arthritis anno 2023. Annals of the rheumatic diseases (2023)
Walter Reinisch, Wayne Hellstrom, Radboud J E M Dolhain, Suresh Sikka, René Westhovens, Rajiv Mehta, Timothy Ritter, Ursula Seidler, Oleksandr Golovchenko, Vladimir Simanenkov, Olena Garmish, Sławomir Jeka, Radka Moravcová, Vijay Rajendran, Franck-Olivier Le Brun, Sarah Arterburn, Timothy R Watkins, Robin Besuyen, Dirk Vanderschueren
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies. Annals of the rheumatic diseases (2023)
P Lebughe Litite, René Westhovens, Aliocha Nkodila Natuhoyila, J J Malemba, Kurt de Vlam
Development and validation of a screening tool for SPondyloArthritis Screening in Sub-Saharan Africa: SpASSS questionnaire. BMC medical research methodology 23 (1) (2023)
Ioannis Parodis, Charlotte Girard-Guyonvarc'h, Laurent Arnaud, Oliver Distler, Andrea Domján, Cornelia H M Van den Ende, Kim Fligelstone, Agnes Kocher, Maddalena Larosa, Martin Lau, Alexandros Mitropoulos, Mwidimi Ndosi, Janet L Poole, Anthony Redmond, Valentin Ritschl, Helene Alexanderson, Yvonne Sjöberg, Gunilla von Perner, Till Uhlig, Cecilia Varju, Johanna E Vriezekolk, Elisabet Welin, René Westhovens, Tanja Alexandra Stamm, Carina Boström
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Annals of the rheumatic diseases (2023)
Michaël Doumen, Sofia Pazmino, Patrick Verschueren, René Westhovens
Viewpoint: Supporting mental health in the current management of rheumatoid arthritis: time to act! Rheumatology (Oxford, England) 62 (SI3) (2023)
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert B M Landewe, Johannes Jw Bijlsma, Andreas Kerschbaumer, René Westhovens, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases 81 (7) (2022)
Sofia Pazmino, Anikó Lovik, René Westhovens, Patrick Verschueren, null null
Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication. The Journal of rheumatology 49 (4) (2022)
Sofia Pazmino, Patrick Verschueren, René Westhovens
JAK inhibition and the holy grail for pain control in early RA. RMD open 8 (1) (2022)
René Westhovens
Filgotinib in rheumatoid arthritis. Expert review of clinical immunology (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Michaël Doumen, Sofia Pazmino, Delphine Bertrand, Diederik De Cock, Johan Joly, René Westhovens, Patrick Verschueren
Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response. Annals of the rheumatic diseases 81 (10) (2022)
Michaël Doumen, Diederik De Cock, Caroline Van Lierde, Albrecht Betrains, Sofia Pazmino, Delphine Bertrand, René Westhovens, Patrick Verschueren
Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis. RMD open 8 (2) (2022)
Daniel Aletaha, René Westhovens, Cecile Gaujoux-Viala, Giovanni Adami, Alan Matsumoto, Paul Bird, Osvaldo Daniel Messina, Maya H Buch, Beatrix Bartok, Zhaoyu Yin, Ying Guo, Thijs Hendrikx, Gerd-Rüdiger R Burmester
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3. RMD open 7 (2) (2021)
René Westhovens
CT-P13 SC for the treatment of rheumatoid arthritis. Expert review of clinical immunology (2021)
Kristien Van der Elst, Diederik De Cock, Lore Bangels, Lianne Peerlings, Michael Doumen, Delphine Bertrand, Lies De Caluwé, Ilse Langers, Veerle Stouten, René Westhovens, Patrick Verschueren
'More than just chitchat': a qualitative study concerning the need and potential format of a peer mentor programme for patients with early rheumatoid arthritis. RMD open 7 (3) (2021)
S Pazmino, P Verschueren, René Westhovens
Does opioid-based pharmacotherapy have a place in rheumatoid arthritis therapy? Expert opinion on pharmacotherapy 22 (15) (2021)
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir et al. Annals of the rheumatic diseases (2021)
Diederik De Cock, Sofia Pazmino, S Pazmino, Delphine Bertrand, Veerle Stouten, René Westhovens, Patrick Verschueren
Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study. Rheumatology international (2021)
Veerle Stouten, Sofia Pazmino, Patrick Verschueren, Pavlos Mamouris, René Westhovens, Kurt de Vlam, Delphine Bertrand, Kristien Van der Elst, Bert Vaes, Diederik De Cock
Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study. RMD open 7 (2) (2021)
René Westhovens, William F C Rigby, Désirée Mfm van der Heijde, Daniel W T Ching, William Stohl, Jonathan Kay, Arvind Chopra, Beatrix Bartok, Franziska Matzkies, Zhaoyu Yin, Ying Guo, Chantal Tasset, John S Sundy, Angelika Jahreis, Neelufar Mozaffarian, Osvaldo Daniel Messina, Robert B M Landewe, Tatsuya Atsumi, Gerd R Burmester
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial. Annals of the rheumatic diseases (2021)
Sofia Pazmino, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, René Westhovens, Patrick Verschueren
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial. RMD open 7 (2) (2021)
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial. Annals of the rheumatic diseases (2021)
Michaël Doumen, Bart Vankelecom, René Westhovens, Stijn Michiels
Pericarditis as a manifestation of IgG4-related disease. Rheumatology international (2021)
HoUng Kim, Rieke E Alten, J R Fraser Cummings, Silvio Danese, Geert R A M D'Haens, Paul Emery, Subrata Ghosh, Cyrielle Gilletta de Saint Joseph, Jong Hyuk Lee, James O Lindsay, Elena Nikiphorou, Ben Parker, Stefan Schreiber, Steven R A Simoens, René Westhovens, Ji Hoon Jeong, Laurent Peyrin-Biroulet
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs 13 (1) (2021)
Annelies Boonen, Polina Putrik, Mary Lucy Marques, Alessia Alunno, Lydia Abasolo, Dorcas Beaton, Neil Betteridge, Mathilda Bjørk, Maarten Boers, Boryana Boteva, Bruno Fautrel, Francis Guillemin, Elsa F Mateus, Elena Nikiphorou, Márta Péntek, Fernando Pimentel Santos, Johannes L Severens, Suzanne M M Verstappen, Karen Walker-Bone, Johan Karlsson Wallman, Marieke M Ter Wee, René Westhovens, Josef S Smolen
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis. Annals of the rheumatic diseases 80 (9) (2021)
HoUng Kim, Rieke E Alten, Luisa Avedano, Axel U Dignass, Fernando Gomollón, Kay Greveson, Jonas Halfvarson, Peter M Irving, Prof Jørgen Jahnsen, Péter L Lakatos, JongHyuk Lee, Souzi Makri, Ben Parker, Laurent Peyrin-Biroulet, Stefan Schreiber, Steven R A Simoens, René Westhovens, Silvio Danese, Ji Hoon Jeong
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Drugs 80 (2) (2020)
Peter Nash, Andreas Kerschbaumer, Thomas Dörner, Maxime Dougados, Roy M Fleischmann, Klaus Geissler, Iain McInnes, Janet E Pope, Désirée Mfm van der Heijde, Michaela Stoffer-Marx, Tsutomu Takeuchi, Michael Trauner, Kevin L Winthrop, Maarten P T de Wit, Daniel Aletaha, Xenofon Baraliakos, Wolf-Henning Boehncke, Paul Emery, John D Isaacs, Joel Kremer, Eun Bong Lee, Walter P Maksymowych, Marieke Voshaar, Lai-Shan Tam, Yoshiya Tanaka, Filip van den Bosch, René Westhovens, Ricardo Xavier, Josef S Smolen
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Annals of the rheumatic diseases 80 (1) (2020)
René Westhovens, Sean E Connolly, J Margaux, M Vanden Berghe, M Maertens, M Van den Berghe, Yedid Elbez, M Chartier, F Baeke, S Robert, Michel G Malaise
Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study. Rheumatology international 40 (9) (2020)
Diederik De Cock, Isaline Soenen, Delphine Bertrand, Sofia Pazmino, Veerle Stouten, René Westhovens, Patrick Verschueren
Correspondence on 'EULAR recommendations for a core data set for pregnancy registries in rheumatology'. Annals of the rheumatic diseases (2020)
Jonas Geuens, Luc Geurts, Thijs Willem Swinnen, René Westhovens, Vero Vanden Abeele
Mobile Health Features Supporting Self-Management Behavior in Patients With Chronic Arthritis: Mixed-Methods Approach on Patient Preferences. JMIR mHealth and uHealth 7 (3) (2019)
Jonas Geuens, Thijs Willem Swinnen, René Westhovens, Kurt de Vlam, Luc Geurts, Vero Vanden Abeele
A Review of Persuasive Principles in Mobile Apps for Chronic Arthritis Patients: Opportunities for Improvement. JMIR mHealth and uHealth 4 (4) (2016)